Axogen, Inc.
AXGN- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000805928
In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 4 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Axogen, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 4 filings
- 4 insiders, $4.66M in total
- Insiders trading
- 4
- Net value
- −$4.66M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Axogen, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Tyndall Joseph A. | Director | 10,650 | Sep 4, 2026 | 4 |
| Began Marc A | EVP & General Counsel | 50,135 | Aug 12, 2026 | 5 |
| Wendell Amy McBride | Director | 107,976 | Aug 12, 2026 | 5 |
| Weiler Kathy Johnson | Director | 0 | Aug 11, 2026 | 5 |
| Thomas Paul | Director | 32,395 | Jun 26, 2026 | 3 |
| Johnson John | Director | 14,150 | Jun 26, 2026 | 4 |
| Burke William P. Mr. | Director | 14,250 | Jun 26, 2026 | 8 |
| Levine Alan M | Director | 50,893 | Jun 26, 2026 | 2 |
| Kemp Jens | Chief Marketing Officer | 72,451 | May 8, 2026 | 4 |
| Hartley Lindsey Marie | CFO | 65,146 | May 8, 2026 | 6 |
| Quackenbush Doris | Sales VP | 92,416 | May 8, 2026 | 1 |
| DeVinney Erick Wayne | Chief Innovation Officer | 262,781 | Mar 18, 2026 | 4 |
| Dale Michael D | Chief Executive Officer | 63,537 | Feb 27, 2026 | 4 |
| Neels Guido J | Director | 86,743 | Jun 11, 2025 | 0 |
| Naor Nir | CFO | 260,868 | Jan 6, 2025 | 0 |
| Freitag Gregory Gene | Director | 283,498 | Jun 6, 2024 | 0 |
| Zaderej Karen L. | CEO | 1,143,788 | Mar 25, 2024 | 0 |
| Donovan Michael Patrick | VP Operations | 54,250 | Mar 25, 2024 | 0 |
| Scopelianos Angelo | Chief R&D Officer | 57,994 | Mar 25, 2024 | 0 |
| Mariani Peter J | EVP & Chief Financial Officer | 63,603 | Dec 13, 2023 | 0 |
| Martinez Maria D. | Chief Human Resources Officer | 30,476 | Oct 13, 2023 | 0 |
| Ottinger Bradley | General Counsel and CCO | 23,627 | Mar 20, 2023 | 0 |
| Billet Isabelle | Chief Strategy and BD Officer | 25,065 | Dec 29, 2022 | 0 |
| Sandberg Eric | Chief Commercial Officer | 16,081 | Jul 20, 2022 | 0 |
| Gold Mark Stephen | Director | 305,475 | Jun 3, 2022 | 0 |
| Blackford Quentin S. | Director | 27,335 | Apr 1, 2022 | 0 |
| Friedman Mark Louis | VP Regulatory Affairs & Policy | 24,343 | Mar 18, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Hartley Lindsey MarieCFO | SSale | −14.8K | $29.86 | −$442.3K | −32.1%31.4K after | |
| Dec 17, 2025 (view filing) | Dec 16 | 1 day | Weiler Kathy JohnsonDirector | SSale | −46.7K | $29.55 | −$1.38M | −100.0%0 after | 3 lots |
| Dec 17, 2025 (view filing) | Dec 16 | 1 day | Wendell Amy McBrideDirector | SSale | −43.7K | $29.31 | −$1.28M | −31.8%93.8K after | 3 lots |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | DeVinney Erick WayneChief Innovation Officer | SSale | −5.22K | $32.84 | −$171.5K | −1.9%262.8K after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Quackenbush DorisSales VP | SSale | −3.88K | $43.51 | −$168.7K | −4.0%92.4K after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Hartley Lindsey MarieCFO | SSale | −1.05K | $43.67 | −$45.9K | −1.6%65.1K after | 2 lots |
| May 8, 2026 (view filing) | May 7 | 1 day | Kemp JensChief Marketing Officer | SSale | −4.00K | $43.44 | −$173.8K | −5.2%72.5K after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Weiler Kathy JohnsonDirector | SSale | −16.3K | $44.09 | −$720.6K | −100.0%0 after | |
| May 8, 2026 (view filing) | May 7 | 1 day | Johnson JohnDirector | SSale | −11.1K | $43.26 | −$478.0K | −100.0%0 after | |
| May 12, 2026 (view filing) | May 8 | 4 days | Wendell Amy McBrideDirector | SSale | −1.65K | $42.60 | −$70.2K | −1.7%93.8K after | |
| Aug 11, 2026 (view filing)4:15 PM ET | Aug 7 | 4 days | Weiler Kathy JohnsonDirector | SSale | −14.2K | $45.30 | −$641.0K | −100.0%0 after | 10b5-1 |
| Aug 12, 2026 (view filing)4:12 PM ET | Aug 11 | 1 day | Wendell Amy McBrideDirector | SSale | −13.4K | $48.42 | −$646.6K | −11.0%108.0K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:13 PM ET | Aug 10 | 2 days | Began Marc AEVP & General Counsel | SSale | −67.5K | $47.35 | −$3.20M | −57.4%50.1K after | 10b5-1 |
| Sep 4, 2026 (view filing)4:08 PM ET | Sep 2 | 2 days | Tyndall Joseph A.Director | SSale | −3.50K | $49.70 | −$173.9K | −24.7%10.7K after | 10b5-1 |